Stay updated on Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.4, replacing the previous v3.6.3. This indicates a minor update to the page content or its metadata.
    Difference
    0.1%
    Check dated 2026-07-25T16:47:05.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.3, replacing the previous v3.6.2 tag.
    Difference
    0.1%
    Check dated 2026-07-04T04:19:57.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page shows a new revision label v3.6.2, indicating a platform update. This update appears to change the version reference rather than the study details or text on the page.
    Difference
    0.1%
    Check dated 2026-06-27T02:50:31.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now displays a recruitment status indicating no participants are being sought and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) to assist visitors. Additionally, the formatting of the Intervention/Treatment label was normalized from 'Intervention / Treatment' and the revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:28:45.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page’s revision tag was updated to v3.5.5, replacing the previous v3.5.4 tag.
    Difference
    0.1%
    Check dated 2026-06-05T13:30:34.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the page. This appears to be a small metadata or formatting update and does not modify study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-05-15T06:55:26.000Z thumbnail image

Stay in the know with updates to Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.